Rising prevalence of gastrointestinal disorders will significantly increase the demand for irritable bowel syndrome with constipation drugs market.
The global irritable bowel syndrome with constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 6.1% during the estimated period from 2022 to 2030.Irritable bowel syndrome (IBS) is defined as persistent abdominal discomfort and pain occurring with changed bowel habits. This condition is classified into three types centered upon the prevalent bowel habits; IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and IBS with mixed presentations (IBS-M). It is among the most common gastrointestinal disorders with a worldwide prevalence of approximately 11%. As of 2021, more than 30 million individuals older than age 19 suffered from IBS across key national markets namely the U.S., U.K. France, Italy, Germany, Japan, and Spain. The IBS market is observed to be underpenetrated and hence is deemed attractive for pharmaceutical manufacturers in the GI drugs market. The majority of IBS patients are women and one-third IBS patients experience constipation as a primary syndrome. Awareness about the attractiveness of the market potential and a growing understanding of disease pathophysiology render growth potential and further evolution of the IBS-C drugs market.
This report on global irritable bowel syndrome with constipation (IBS-C) drugs evaluates the current market scenario and predicts future market trends for the commercialized and pipeline drugs for IBS-C treatment for the period from 2020 to 2030. IBS is among the most commonly prevalent gastrointestinal diseases for which the exact cause is not determined. However, the recent developments in research on this issue have led to the introduction of several novel disease treatment and management solutions.
In addition, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more people staying at home. Hence, lack of exercise and consumption of spicy food has resulted in the development of irritable bowel syndrome across all age groups. In addition, irrational intake of medication has also been linked to causing a change in the gut microflora causing underlying factors for the occurrence of IBS, thereby the irritable bowel syndrome with constipation drugs market is expected to witness significant growth during the forecast period from 2022 to 2030.
Sedentary lifestyle and irrational intake of medication has led to the occurrence of IBS across all age group in the North America region
In 2021, North America dominated the regional irritable bowel syndrome with constipation drugs market, due to increased intake of irrational medications and lack of exercise, thereby causing irritable bowel syndrome associated with constipation. Existence of a well-developed healthcare infrastructure and the presence of major market players such as Abbott Laboratories, Inc., Ardelyx. Inc., Astellas Pharma Inc., AstraZeneca Plc., Bayer AG, Fresenius Kabi AG., and others further accentuate the market growth in the region.Increasing consumption of spicy food will spur the market in the Asia Pacific region
The Asia Pacific region is expected to be the fastest-growing region during the forecast period owing to the increasing consumption of spicy food, drastically altering the bowel peristaltic activity and increasing public health awareness regarding gastrointestinal disorders and its effective management will drive the market growth in Asia Pacific region.This report is a comprehensive research study of the global irritable bowel syndrome with constipation drugs market that elaborates the major trends in the market based on quantitative and qualitative research. This report provides a detailed description of global irritable bowel syndrome with constipation drugs market segmenting market by drug types, prescription type, and geography. This report aids the market stakeholders to make improved decisions and strategies in the irritable bowel syndrome with constipation drugs market.
Historical - Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Irritable Bowel Syndrome with Constipation Drugs market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Irritable Bowel Syndrome with Constipation Drugs market and their expected impact during the forecast period.
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Irritable Bowel Syndrome with Constipation Drugs market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Irritable Bowel Syndrome with Constipation Drugs market?
- Which is the largest regional market for Irritable Bowel Syndrome with Constipation Drugs market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East - Africa?
- Which are the key trends driving Irritable Bowel Syndrome with Constipation Drugs market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Irritable Bowel Syndrome with Constipation Drugs market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Irritable Bowel Syndrome with Constipation Drugs Market
2.2. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2021 (US$ Million)
2.3. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2021 (US$ Million)
2.4. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Geography, 2021 (US$ Million)
2.5. Impact of Covid 19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Irritable Bowel Syndrome with Constipation Drugs Market Vendors
2.7.2. Strategies Adopted by Irritable Bowel Syndrome with Constipation Drugs Market Vendors
2.7.3. Key Industry Strategies
2.7.4. Tier Analysis 2021 Versus 2030
2.8. Key Buying Criteria
2.9. Key Case Reports
2.10. Scenario Analysis
2.10.1. Optimistic estimates and analysis
2.10.2. Realistic estimates and analysis
2.10.3. Pessimistic estimates and analysis
2.11. Market Profiling
2.12. Sales and Marketing Plan
2.13. Top Market Conclusions
2.14. Strategic Recommendations
3. Irritable Bowel Syndrome with Constipation Drugs Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Irritable Bowel Syndrome with Constipation Drugs Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Lubiprostone
4.3.2. Linaclotide
4.3.3. Stimulant Laxatives - Bisacodyl
4.3.4. Osmotic Laxatives
4.3.5. Lactulose
4.3.6. Polyethylene Glycol5. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Prescribed
5.3.2. Over the Counter Type (OTC)
6. North America Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
6.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
6.4.1. North America
6.4.1.1. U.S.
6.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
6.4.1.2. Canada
6.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
6.4.1.3. Rest of North America
6.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7. UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
7.4.1. UK and European Union
7.4.1.1. UK
7.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.2. Germany
7.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.3. Spain
7.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.4. Italy
7.4.1.4.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.4.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.5. France
7.4.1.5.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.5.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.6. Rest of Europe
7.4.1.6.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
8.4.1. Asia Pacific
8.4.1.1. China
8.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.2. Japan
8.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.3. India
8.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.4. Australia
8.4.1.4.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.4.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.5. South Korea
8.4.1.5.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.5.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.6. Rest of Asia Pacific
8.4.1.6.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
9.4.1. Latin America
9.4.1.1. Brazil
9.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9.4.1.2. Mexico
9.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9.4.1.3. Rest of Latin America
9.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
10.4.1. Middle East and Africa
10.4.1.1. GCC
10.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10.4.1.2. Africa
10.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10.4.1.3. Rest of Middle East and Africa
10.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
11. Company Profile
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Ardelyx, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Astellas Pharma Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. AstraZeneca Plc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Bayer AG
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Fresenius Kabi AG
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Ironwood Pharmaceuticals, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Sanofi S.A.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. SK Biopharmaceuticals Co., Ltd.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Sucampo AG
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Synergy Pharmaceuticals, Inc.
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Synthetic Biologics, Inc.
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Irritable Bowel Syndrome with Constipation Drugs Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Irritable Bowel Syndrome with Constipation Drugs Market: Quality Assurance
Figure 5 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2021
Figure 6 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2021
Figure 7 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Irritable Bowel Syndrome with Constipation Drugs Market, 2021
Figure 9 Market Positioning of Key Irritable Bowel Syndrome with Constipation Drugs Market Players, 2021
Figure 10 Global Irritable Bowel Syndrome with Constipation Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 12 See Saw Analysis
Figure 13 PETEL Analysis
Figure 14 Key Buying Criteria: Current and Long-Term Perspective
Figure 15 Global Irritable Bowel Syndrome with Constipation Drugs Market, Scenario Analysis, 2020 to 2030 (US$ Million)
Figure 16 Heptalysis Analysis: Global Irritable Bowel Syndrome with Constipation Drugs Market
Figure 17 Five Whys Analysis
Figure 18 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2021 Vs 2030, %
Figure 19 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2021 Vs 2030, %
Figure 20 U.S. Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 21 Canada Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 22 Rest of North America Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 23 UK Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 24 Germany Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 25 Spain Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 26 Italy Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 27 France Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 28 Rest of Europe Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 29 China Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 30 Japan Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 31 India Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 32 Australia Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 33 South Korea Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 34 Rest of Asia Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 35 Brazil Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 36 Mexico Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 37 Rest of Latin America Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 38 GCC Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 39 Africa Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 40 Rest of Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030List of Tables
Table 1 Global Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 2 Global Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 3 North America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 4 North America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 5 U.S. Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 6 U.S. Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 7 Canada Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 8 Canada Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 9 Rest of North America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 10 Rest of North America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 11 UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 12 UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 13 UK Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 14 UK Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 15 Germany Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 16 Germany Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 17 Spain Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 18 Spain Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 19 Italy Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 20 Italy Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 21 France Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 22 France Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 23 Rest of Europe Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 24 Rest of Europe Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 25 Asia Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 26 Asia Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 27 China Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 28 China Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 29 Japan Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 30 Japan Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 31 India Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 32 India Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 33 Australia Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 34 Australia Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 35 South Korea Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 36 South Korea Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 37 Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 38 Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 39 Brazil Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 40 Brazil Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 41 Mexico Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 42 Mexico Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 43 Rest of Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 44 Rest of Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 45 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 46 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 47 GCC Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 48 GCC Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 49 Africa Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 50 Africa Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Companies Mentioned
- Abbott Laboratories Inc.
- Ardelyx Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc.
- Bayer AG
- Fresenius Kabi AG
- Ironwood Pharmaceuticals Inc.
- Sanofi S.A.
- SK Biopharmaceuticals Co. Ltd.
- Sucampo AG
- Synergy Pharmaceuticals Inc.
- Synthetic Biologics Inc
